MARKET COMPOSITE
B - Barnes Group Inc.8:00:01 PM 4/22/2024
Price
$35.86
+ 0.10 (0.28%)
Founded in 1857, Barnes Group Inc. is a global industrial and aerospace manufacturer and service provider, serving a wide range of end markets and customers. Thomas Barnes is a member of the Connecticut Public Television Board of Trustees.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue415.5MM+15%
Gross Profit111.1MM-
Cost Of Revenue304.4MM+20%
Operating Income29.7MM-
Operating Expenses81.4MM-
Net Income7.2MM-133%
G&A81.4MM-17%
Amortization21.6MM+15%
Interest Expense23.6MM+3%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    BRISTOL, Conn., April 09, 2024--Barnes Aerospace proudly announces the completion of its newly expanded Maintenance, Repair, and Overhaul (MRO) facility in East Granby, Connecticut. The project provides an additional 32,000 square feet of manufacturing space, bringing the facility total to more than 84,000 square feet. The facility specializes in highly complex repairs of cases, frames, diffusers, bearing housings, and major rotating hardware across a vast array of commercial and military engine

    BRISTOL, Conn., April 04, 2024--Barnes Group Inc. (NYSE: B) today announced the completion of its previously announced sale of its Associated Spring™ and Hänggi™ businesses to One Equity Partners.

    BRISTOL, Conn., March 20, 2024--Barnes Group Inc. (NYSE: B) today announced it will release first quarter 2024 financial results on Friday, April 26, 2024, before the market opens.

    BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease. According to Eisai's simulation, Leqembi sales will reach JPY 290 billion for their financial year (FY) 2026, which ends in March 2027 and JPY 1.6 trillion in FY2032.

    BRISTOL, Conn., March 05, 2024--Barnes Group Inc. (NYSE: B), a global provider of highly engineered products, differentiated industrial technologies, and innovative solutions, today announced the planned retirements of Chairman Thomas O. Barnes and Lead Independent Director Mylle H. Mangum, consistent with the Company’s corporate governance retirement policy, effective at the Company’s Annual Meeting of Stockholders in May 2024. Mr. Barnes will become Chairman Emeritus and continue to lead the B

    Barnes Group ( NYSE:B ) Full Year 2023 Results Key Financial Results Revenue: US$1.45b (up 15% from FY 2022). Net...

    BRISTOL, Conn., February 21, 2024--In the face of critical aerospace engine component repair capacity constraints within the aerospace industry, Barnes Aerospace is excited to announce that it has added a new component repair facility in Singapore. Barnes Aerospace’s component repair capacity to support customers’ needs in the region will increase, as does the facility footprint by approximately 50%.

    Last week saw the newest full-year earnings release from Barnes Group Inc. ( NYSE:B ), an important milestone in the...

    Barnes Group Inc. (NYSE:B) Q4 2023 Earnings Call Transcript February 16, 2024 Barnes Group Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Krista and I will be your conference operator today. At this time […]

    NEW YORK, February 16, 2024--Irenic Capital Management LP (together with its affiliates, "Irenic" or "we"), a top shareholder of Barnes Group Inc. (NYSE: B) ("Barnes" or the "Company") and the beneficial owner of approximately 5.1% of the Company’s outstanding common stock, today issued the following statement from Co-Founder and Chief Investment Officer Adam Katz: